Association of PDA treatment in extremely low gestational age neonates with two-year kidney outcomes: results from the PENUT study
Saturday, May 4, 2024
2:00 PM – 2:15 PM ET
Location: Metro Toronto Convention Centre: 801 B
CE Enduring CME: 0.25
Publication Number: 2145.1
Paige Condit, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States; Ronnie Guillet, Golisano Children's Hospital at The University of Rochester Medical Center, Rochester, GA, United States; Russell Griffin, University of Alabama at Birmingham, Birmingham, AL, United States; David Askenazi, University of Alabama at Birmingham, Birmingham, AL, United States; Matthew W. Harer, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States
Presenting Author(s)
PC
Paige Condit, MD (she/her/hers)
NICU Fellow University of Wisconsin School of Medicine and Public Health Madison, Wisconsin, United States
Paige Condit, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Ronnie Guillet, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Russell Griffin, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
David Askenazi, MD, MSPH: Abbott (Ongoing) (Products/Services: Consultant); Baxter (Ongoing) (Products/Services: Consultant); Bioporto (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator); leadiant (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Nuwellis (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator); Seastar (Ongoing) (Products/Services: Consultant); Zorro-Flow Inc. (Ongoing) (Products/Services: Intellectual Property including patent beneficiary and royalties, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)
Matthew W. Harer, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
